Swedish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Chosa Oncology

Market Cap: SEK 34.4m

Develops oncology drugs cisplatin for the treatment of cancer.

AcuCort

Market Cap: SEK 170.7m

Develops and commercializes glucocorticoid dexamethasone films for the treatment of acute allergic conditions.

Saniona

Market Cap: SEK 1.9b

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.

Sprint Bioscience

Market Cap: SEK 379.9m

A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.

Inhalation Sciences Sweden

Market Cap: SEK 65.8m

Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.

Abera Bioscience

Market Cap: SEK 135.3m

A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.

Elicera Therapeutics

Market Cap: SEK 151.9m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

Orexo

Market Cap: SEK 649.5m

A pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally.

Camurus

Market Cap: SEK 30.7b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Corline Biomedical

Market Cap: SEK 462.6m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.

Medivir

Market Cap: SEK 967.5m

A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.

KDventures

Market Cap: SEK 187.2m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

Aptahem

Market Cap: SEK 16.4m

A biotechnology company, engages in the development of ribonucleic acid-based pharmaceuticals in Sweden.

Dextech Medical

Market Cap: SEK 132.2m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

Genovis AB (publ.)

Market Cap: SEK 1.4b

Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.

Flerie

Market Cap: SEK 2.3b

A venture capital firm specializing in early-stage investments.

Bonesupport Holding

Market Cap: SEK 15.8b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Spermosens

Market Cap: SEK 31.7m

Provides diagnostic health care products and services in Sweden.

Devyser Diagnostics

Market Cap: SEK 1.5b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

IDL Diagnostics

Market Cap: SEK 101.4m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

Pila Pharma

Market Cap: SEK 79.0m

Operates as a clinical stage biotech company in Sweden.

BioGaia

Market Cap: SEK 13.3b

A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.

BioArctic

Market Cap: SEK 28.7b

Develops biological drugs for patients with central nervous system disorders in Sweden.

Diamyd Medical

Market Cap: SEK 178.2m

Develops precision medicine therapies for the treatment of autoimmune diabetes.

SynAct Pharma

Market Cap: SEK 796.3m

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Cantargia

Market Cap: SEK 847.8m

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

Biovica International

Market Cap: SEK 98.1m

A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the European Union, United States of America, and internationally.

Infant Bacterial Therapeutics

Market Cap: SEK 773.3m

Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.

BICO Group

Market Cap: SEK 1.3b

Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.

Cinclus Pharma Holding

Market Cap: SEK 565.9m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

ODI Pharma

Market Cap: SEK 70.8m

A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.

Level Bio

Market Cap: SEK 18.6m

Manufactures and distributes cutting-edge and diagnostic solutions in the Nordic region and internationally.

AlzeCure Pharma

Market Cap: SEK 167.8m

Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.

MedCap

Market Cap: SEK 8.2b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.

Isofol Medical

Market Cap: SEK 221.1m

Operates as a clinical stage biotech company.

Intervacc

Market Cap: SEK 387.8m

Develops novel veterinary vaccines for animals in Sweden.